Paul Actor
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 15
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 26
- Endocrinology top 10%
- Vibrio bacteria research studies 5
- Escherichia coli research studies 5
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 7
- Antifungal resistance and susceptibility 6
- Microbiology top 10%
-
- Phenothiazines and Benzothiazines Synthesis and Activities 11
- Cancer therapeutics and mechanisms 5
- Co-authors
- Jerry A. WeisbachDonald PitkinGeorge L. DunnJohn R. E. HooverIan ZajacSarah F. GrappelRobert M. DeMarinisDavid A. Berges
- Journals
- The Journal of Antibiotics (21 papers)Antimicrobial Agents and Chemotherapy (10 papers)Infection and Immunity (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Paul Actor
69 papers receiving 795 citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 177
- Pharmacology 320
- Endocrinology 68
- Infectious Diseases 231
- Microbiology 61
Countries citing papers authored by Paul Actor
This map shows the geographic impact of Paul Actor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Actor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Actor more than expected).
Fields of papers citing papers by Paul Actor
This network shows the impact of papers produced by Paul Actor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Actor. The network helps show where Paul Actor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Actor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 12 | |
| 2 | 1994 | 14 | |
| 3 | Antibiotic inhibition of bacterial cell surface assembly and function | 1988 | 191 |
| 4 | 1984 | 3 | |
| 5 | 1984 | 1 | |
| 6 | 1984 | 1 | |
| 7 | 1984 | 36 | |
| 8 | 1983 | 7 | |
| 9 | 1982 | 4 | |
| 10 | 1981 | 9 | |
| 11 | 1981 | 10 | |
| 12 | 1980 | 8 | |
| 13 | 1980 | 8 | |
| 14 | 1980 | 1 | |
| 15 | 1979 | 12 | |
| 16 | 1975 | 10 | |
| 17 | 1974 | 20 | |
| 18 | 1972 | 6 | |
| 19 | 1969 | 8 | |
| 20 | 1962 | 7 |
About Paul Actor
Paul Actor is a scholar working on Molecular Medicine, Pharmacology and Endocrinology, having authored 72 papers that have together received 988 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Antibiotic Resistance in Bacteria (15 papers), Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antifungal resistance and susceptibility (6 papers), Vibrio bacteria research studies (5 papers), Cancer therapeutics and mechanisms (5 papers) and Escherichia coli research studies (5 papers). The work is most often cited by research in Molecular Medicine (177 citations), Pharmacology (320 citations) and Endocrinology (68 citations). Paul Actor has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jerry A. Weisbach, Donald Pitkin, George L. Dunn, John R. E. Hoover, Ian Zajac, Sarah F. Grappel, Robert M. DeMarinis, David A. Berges, John F. Pauls and William D. Kingsbury. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Infection and Immunity, Journal of Clinical Microbiology and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.